C-terminal truncation and Parkinson's disease-associated mutations down-regulate the protein serine/threonine kinase activity of PTEN-induced kinase-1 - PubMed (original) (raw)
. 2006 Nov 1;15(21):3251-62.
doi: 10.1093/hmg/ddl398. Epub 2006 Sep 25.
Affiliations
- PMID: 17000703
- DOI: 10.1093/hmg/ddl398
C-terminal truncation and Parkinson's disease-associated mutations down-regulate the protein serine/threonine kinase activity of PTEN-induced kinase-1
Chou Hung Sim et al. Hum Mol Genet. 2006.
Abstract
The Parkinson's disease (PD) causative PINK1 gene encodes a mitochondrial protein kinase called PTEN-induced kinase 1 (PINK1). The autosomal recessive pattern of inheritance of PINK1 mutations suggests that PINK1 is neuroprotective and therefore loss of PINK1 function causes PD. Indeed, overexpression of PINK1 protects neuroblastoma cells from undergoing neurotoxin-induced apoptosis. As a protein kinase, PINK1 presumably exerts its neuroprotective effect by phosphorylating specific mitochondrial proteins and in turn modulating their functions. Towards elucidation of the neuroprotective mechanism of PINK1, we employed the baculovirus-infected insect cell system to express the recombinant protein consisting of the PINK1 kinase domain either alone [PINK1(KD)] or with the PINK1 C-terminal tail [PINK1(KD+T)]. Both recombinant enzymes preferentially phosphorylate the artificial substrate histone H1 exclusively at serine and threonine residues, demonstrating that PINK1 is indeed a protein serine/threonine kinase. Introduction of the PD-associated mutations, G386A and G409V significantly reduces PINK1(KD) kinase activity. Since Gly-386 and Gly-409 reside in the conserved activation segment of the kinase domain, the results suggest that the activation segment is a regulatory switch governing PINK1 kinase activity. We also demonstrate that PINK1(KD+T) is approximately 6-fold more active than PINK1(KD). Thus, in addition to the activation segment, the C-terminal tail also contains regulatory motifs capable of governing PINK1 kinase activity. Finally, the availability of active recombinant PINK1 proteins permits future studies to search for mitochondrial proteins that are preferentially phosphorylated by PINK1. As these proteins are likely physiological substrates of PINK1, their identification will shed light on the mechanism of pathogenesis of PD.
Similar articles
- Analysis of the regulatory and catalytic domains of PTEN-induced kinase-1 (PINK1).
Sim CH, Gabriel K, Mills RD, Culvenor JG, Cheng HC. Sim CH, et al. Hum Mutat. 2012 Oct;33(10):1408-22. doi: 10.1002/humu.22127. Epub 2012 Jul 5. Hum Mutat. 2012. PMID: 22644621 Review. - Phylogenetic and in silico structural analysis of the Parkinson disease-related kinase PINK1.
Cardona F, Sánchez-Mut JV, Dopazo H, Pérez-Tur J. Cardona F, et al. Hum Mutat. 2011 Apr;32(4):369-78. doi: 10.1002/humu.21444. Hum Mutat. 2011. PMID: 21412950 - Biochemical aspects of the neuroprotective mechanism of PTEN-induced kinase-1 (PINK1).
Mills RD, Sim CH, Mok SS, Mulhern TD, Culvenor JG, Cheng HC. Mills RD, et al. J Neurochem. 2008 Apr;105(1):18-33. doi: 10.1111/j.1471-4159.2008.05249.x. Epub 2008 Jan 23. J Neurochem. 2008. PMID: 18221368 Review. - Genetic mutations and functions of PINK1.
Kawajiri S, Saiki S, Sato S, Hattori N. Kawajiri S, et al. Trends Pharmacol Sci. 2011 Oct;32(10):573-80. doi: 10.1016/j.tips.2011.06.001. Epub 2011 Jul 23. Trends Pharmacol Sci. 2011. PMID: 21784538 Review. - Discovery of catalytically active orthologues of the Parkinson's disease kinase PINK1: analysis of substrate specificity and impact of mutations.
Woodroof HI, Pogson JH, Begley M, Cantley LC, Deak M, Campbell DG, van Aalten DM, Whitworth AJ, Alessi DR, Muqit MM. Woodroof HI, et al. Open Biol. 2011 Nov;1(3):110012. doi: 10.1098/rsob.110012. Open Biol. 2011. PMID: 22645651 Free PMC article.
Cited by
- PINK1 stimulates interleukin-1β-mediated inflammatory signaling via the positive regulation of TRAF6 and TAK1.
Lee HJ, Jang SH, Kim H, Yoon JH, Chung KC. Lee HJ, et al. Cell Mol Life Sci. 2012 Oct;69(19):3301-15. doi: 10.1007/s00018-012-1004-7. Epub 2012 May 29. Cell Mol Life Sci. 2012. PMID: 22643835 Free PMC article. - PINK1-mediated phosphorylation of the Parkin ubiquitin-like domain primes mitochondrial translocation of Parkin and regulates mitophagy.
Shiba-Fukushima K, Imai Y, Yoshida S, Ishihama Y, Kanao T, Sato S, Hattori N. Shiba-Fukushima K, et al. Sci Rep. 2012;2:1002. doi: 10.1038/srep01002. Epub 2012 Dec 19. Sci Rep. 2012. PMID: 23256036 Free PMC article. Clinical Trial. - Mitochondrial cell death control in familial Parkinson disease.
Kroemer G, Blomgren K. Kroemer G, et al. PLoS Biol. 2007 Jul;5(7):e206. doi: 10.1371/journal.pbio.0050206. Epub 2007 Jul 17. PLoS Biol. 2007. PMID: 17638420 Free PMC article. - Structure and Function of Parkin, PINK1, and DJ-1, the Three Musketeers of Neuroprotection.
Trempe JF, Fon EA. Trempe JF, et al. Front Neurol. 2013 Apr 19;4:38. doi: 10.3389/fneur.2013.00038. eCollection 2013. Front Neurol. 2013. PMID: 23626584 Free PMC article. - Chaperone-dependent Neurodegeneration: A Molecular Perspective on Therapeutic Intervention.
Carman A, Kishinevsky S, Koren J 3rd, Lou W, Chiosis G. Carman A, et al. J Alzheimers Dis Parkinsonism. 2013 Apr;2013(Suppl 10):007. doi: 10.4172/2161-0460.S10-007. J Alzheimers Dis Parkinsonism. 2013. PMID: 25258700 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials